Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study
- PMID: 38236192
- DOI: 10.1164/rccm.202212-2330OC
Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study
Abstract
Rationale: The term "pre-chronic obstructive pulmonary disease" ("pre-COPD") refers to individuals at high risk of developing COPD who do not meet conventional spirometric criteria for airflow obstruction. New approaches to identifying these individuals are needed, particularly in younger populations. Objectives: To determine whether lung function thresholds and respiratory symptoms can be used to identify individuals at risk of developing COPD. Methods: The Tasmanian Longitudinal Health Study comprises a population-based cohort first studied in 1968 (at age 7 yr). Respiratory symptoms, pre- and post-bronchodilator (BD) spirometry, diffusing capacity, and static lung volumes were measured in a subgroup at age 45, and the incidence of COPD was assessed at age 53. For each lung function measure, z-scores were calculated using Global Lung Function Initiative references. The optimal threshold for best discrimination of COPD incidence was determined by the unweighted Youden index. Measurements and Main Results: Among 801 participants who did not have COPD at age 45, the optimal threshold for COPD incidence by age 53 was pre-BD FEV1/FVC z-score less than -1.264, corresponding to the lowest 10th percentile. Those below this threshold had a 36-fold increased risk of developing COPD over an 8-year follow-up period (risk ratio, 35.8; 95% confidence interval, 8.88 to 144), corresponding to a risk difference of 16.4% (95% confidence interval, 3.7 to 67.4). The sensitivity was 88%, and the specificity was 87%. Positive and negative likelihood ratios were 6.79 and 0.14, respectively. Respiratory symptoms, post-BD spirometry, diffusing capacity, and static lung volumes did not improve on the classification achieved by pre-BD FEV1/FVC alone. Conclusions: This is the first study, to our knowledge, to evaluate the discriminatory accuracy of spirometry, diffusing capacity, and static lung volume thresholds for COPD incidence in middle-aged adults. Our findings support the inclusion of pre-BD spirometry in the physiological definition of pre-COPD and indicate that pre-BD FEV1/FVC at the 10th percentile accurately identifies individuals at high risk of developing COPD in community-based settings.
Keywords: COPD; diffusing capacity; lung volumes; pre-COPD; spirometry.
Comment in
-
Funding Population-based Cohorts: Still Relevant for Respiratory Epidemiology in the Era of Big Data.Am J Respir Crit Care Med. 2024 Jun 15;209(12):1417-1418. doi: 10.1164/rccm.202401-0172ED. Am J Respir Crit Care Med. 2024. PMID: 38358824 Free PMC article. No abstract available.
Similar articles
-
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254212. doi: 10.1177/17534666241254212. Ther Adv Respir Dis. 2024. PMID: 38841799 Free PMC article.
-
Lung function decline and incidence of chronic obstructive pulmonary disease in participants with spirometry-defined small airway dysfunction: a 15-year prospective cohort study in China.Respir Res. 2025 Apr 28;26(1):169. doi: 10.1186/s12931-025-03244-3. Respir Res. 2025. PMID: 40296032 Free PMC article.
-
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.Eur Respir J. 2025 Feb 6;65(2):2401603. doi: 10.1183/13993003.01603-2024. Print 2025 Feb. Eur Respir J. 2025. PMID: 39638416 Free PMC article. Review.
-
Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.Lancet Respir Med. 2023 Mar;11(3):273-282. doi: 10.1016/S2213-2600(22)00364-2. Epub 2022 Oct 14. Lancet Respir Med. 2023. PMID: 36244396
-
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28919728 Free PMC article. Review.
Cited by
-
Funding Population-based Cohorts: Still Relevant for Respiratory Epidemiology in the Era of Big Data.Am J Respir Crit Care Med. 2024 Jun 15;209(12):1417-1418. doi: 10.1164/rccm.202401-0172ED. Am J Respir Crit Care Med. 2024. PMID: 38358824 Free PMC article. No abstract available.
-
Bronchodilator responsiveness and future chronic airflow obstruction: a multinational longitudinal study.EClinicalMedicine. 2025 Feb 21;81:103123. doi: 10.1016/j.eclinm.2025.103123. eCollection 2025 Mar. EClinicalMedicine. 2025. PMID: 40083442 Free PMC article.
-
Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease.Respirology. 2025 Jul;30(7):574-586. doi: 10.1111/resp.70062. Epub 2025 May 28. Respirology. 2025. PMID: 40437348 Free PMC article. Review.
-
Towards early detection and disease interception of COPD across the lifespan.Eur Respir Rev. 2025 Jul 9;34(177):240243. doi: 10.1183/16000617.0243-2024. Print 2025 Jul. Eur Respir Rev. 2025. PMID: 40633975 Free PMC article. Review.
-
Optimal spirometry thresholds for the prediction of chronic airflow obstruction: a multinational longitudinal study.ERJ Open Res. 2025 Mar 3;11(2):00624-2024. doi: 10.1183/23120541.00624-2024. eCollection 2025 Mar. ERJ Open Res. 2025. PMID: 40040898 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical